Fundz

PURE Bioscience Secures $555,000 in Private Placement Financing

PUBLIC · PUREOct 15, 2026

Amount Raised

$555,000

Round Type

Post-IPO Equity

El CajonOtherBiotechnology

Investors

Tom Y. Lee

Description

On October 15, 2026, PURE Bioscience, Inc. completed a private placement financing, raising $555,000 from accredited investors. The company issued 10,183,486 shares at a purchase price of $0.0545 per share. The proceeds are intended for general corporate purposes, including research and development efforts

Who to call at PURE Bioscience, and when

A new round usually means PURE Bioscience is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day PURE Bioscience raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at PURE Bioscience, from your own LinkedIn network
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

PURE Bioscience

Location

El Cajon, California, United States

About

PURE Bioscience, Inc. is focused on developing and commercializing proprietary antimicrobial products primarily in the food safety arena.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment PURE Bioscience raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

1 contact
Verified contactsTim S., Vice President Sales MarketingSee plans and pricing
Predictive Intelligence
Strategic

ML-powered predictions for PURE Bioscience's next move

See what Strategic adds

PURE Bioscience raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include FundzWatch™ for automated website change detection, Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.